Meral Şen, Duygu Özol, Mikdat Bozer
Index: Dig. Dis. Sci. 54(12) , 2742-7, (2009)
Full Text: HTML
Pain and diaphragmatic dysfunction are the major reasons for postoperative pulmonary complications after upper abdominal surgery. Preoperative administration of analgesics helps to reduce and prevent pain. The objective of this study was first to research the rate of pulmonary complications for laparoscopic cholecystectomy (LC) and then analyze the influence of preemptive analgesia on pulmonary functions and complications. Seventy patients scheduled for elective LC were included in our double-blind, randomized, placebo-controlled, prospective study. Randomly, 35 patients received 1 g etofenamate (group 1) and 35 patients 0.9% saline (group 2) intramuscularly 1 h before surgery. All patients underwent physical examination, chest radiography, lung function tests, and pulse oxygen saturation measurements 2 h before surgery and postoperatively on day 2. Atelectasis was graded as micro, focal, segmental, or lobar. With preemptive analgesia, the need for postoperative analgesia decreased significantly in group 1. In both groups mean spirometric values were reduced significantly after the operation, but the difference and proportional change according to preoperative recordings were found to be similar [29.5 vs. 31.3% reduction in forced vital capacity (FVC) and 32.9 vs. 33.5% reduction in forced expiratory volume in 1 s (FEV(1)) for groups 1 and 2, respectively]. There was an insignificant drop in oxygen saturation rates for both groups. The overall incidence of atelectasia was similar for group 1 and 2 (30.2 vs. 29.2%). Although the degree of atelectesia was found to be more severe in the placebo group, the difference was not statistically significant. We concluded that although preemptive analgesia decreased the need for postoperative analgesia, this had no effect on pulmonary functions and pulmonary complications.© Springer Science+Business Media, LLC 2008
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Etofenamate
CAS:30544-47-9 |
C18H18F3NO4 |
|
Adverse reaction of topical etofenamate: petechial eruption.
2012-10-01 [West Indian Med. J. 61(7) , 767-9, (2012)] |
|
Turpentine sensitization in a nonsteroidal anti-inflammatory...
2012-01-01 [Dermatitis 23(4) , 182-3, (2012)] |
|
Assessing the removal of pharmaceuticals and personal care p...
2012-06-01 [Environ. Sci. Pollut. Res. Int. 19(5) , 1818-27, (2012)] |
|
[Plasma- and tissue concentrations following intramuscular a...
1992-12-01 [Arzneimittelforschung 42(12) , 1487-91, (1992)] |
|
Effects of some pharmacological agents on the survival of un...
2001-01-01 [Microsurgery 21(8) , 350-6, (2001)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
